← Back to Search

Behavioural Intervention

CGM + Behavioral Intervention for Type 2 Diabetes

N/A
Recruiting
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up steps per day will be measured continuously during the 10-week study. average steps per day will be computed for the baseline/run-in period (2 weeks in duration) and every two weeks during the intervention period (8 weeks in duration).
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if using CGM & text-based behavior changes can improve glycemic regulation & diabetes distress in adults w/type 2 diabetes.

Who is the study for?
This trial is for adults over 45 with type 2 diabetes who are able to walk and use a smartphone. They should have high blood sugar levels (A1C ≥8.0%) and feel stressed about their diabetes. People using dialysis, pregnant women, non-English speakers, or those unable to follow the study plan can't join.
What is being tested?
The study tests if continuous glucose monitoring combined with text messages encouraging physical activity or improving mood helps control blood sugar and reduces stress in diabetics. Participants wear sensors and get alternating interventions every two weeks for eight weeks after an initial observation period.
What are the potential side effects?
There may be minimal side effects from wearing CGM sensors like skin irritation. The behavioral change texts might not have direct side effects but could influence mood or activity levels.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~steps per day will be measured continuously during the 10-week study. average steps per day will be computed for the baseline/run-in period (2 weeks in duration) and every two weeks during the intervention period (8 weeks in duration).
This trial's timeline: 3 weeks for screening, Varies for treatment, and steps per day will be measured continuously during the 10-week study. average steps per day will be computed for the baseline/run-in period (2 weeks in duration) and every two weeks during the intervention period (8 weeks in duration). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Diabetes Distress
Change in Glucose Time in Range
Secondary study objectives
Change in Depressive Symptom Severity
Change in Diabetes Self-Management Behavior
Change in Health-Related Problem-Solving
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: CGM paired with behavior change technique interventions, physical activity intervention firstExperimental Treatment4 Interventions
Participants in this arm will receive a continuous glucose monitor and they will receive two behavior change technique interventions via daily text messages over the course of eight weeks, in a series of four, two-week blocks. In the first two-week block, they will receive the physical activity behavior change technique intervention. In the second and third two-week blocks, they will receive the mood behavior change technique intervention. In the fourth two-week block, they will receive the physical activity behavior change technique intervention.
Group II: CGM paired with behavior change technique interventions, mood intervention firstExperimental Treatment4 Interventions
Participants in this arm will receive a continuous glucose monitor and they will receive two behavior change technique interventions via daily text messages over the course of eight weeks, in a series of four, two-week blocks. In the first two-week block, they will receive the mood behavior change technique intervention. In the second and third two-week blocks, they will receive the physical activity behavior change technique intervention. In the fourth two-week block, they will receive the mood behavior change technique intervention.

Find a Location

Who is running the clinical trial?

Northwell HealthLead Sponsor
475 Previous Clinical Trials
469,224 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,805 Previous Clinical Trials
28,194,797 Total Patients Enrolled

Media Library

Action Planning for Mood (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05941000 — N/A
Type 2 Diabetes Research Study Groups: CGM paired with behavior change technique interventions, mood intervention first, CGM paired with behavior change technique interventions, physical activity intervention first
Type 2 Diabetes Clinical Trial 2023: Action Planning for Mood Highlights & Side Effects. Trial Name: NCT05941000 — N/A
Action Planning for Mood (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05941000 — N/A
~20 spots leftby Mar 2025